Drawing for ACTAVIS LABORATORIES

USPTO serial 79130027

ACTAVIS LABORATORIES

Reviewed by CopyMark Law Group

Reg. 4686257Status 404
Filing date
Status date
Registration date
Feb 17, 2015
Examiner
YARD, JOHN S
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ACTAVIS LABORATORIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gabrielle S. Roth

GABRIELLE S ROTH SUGHRUE MION PLLC2100 PENNSYLVANIA AVENUE NWWASHINGTON, DC 20037-3213UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry and science, namely, active chemical ingredients for use in the manufacture of pharmaceuticals for the prevention and treatment of illnesses, diseases and disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the sensory system, and the genitourinary system, in the treatment of inflammatory disorders and diseases, and for treatment in dermatology, oncology, hematology, tissue and organ transplantation, ophthalmology and gastroenterology; and chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes; chemical preparations for use in industrySECTION 71 - CANCELLED—
003Soaps; Perfumery; Essential Oils; Cosmetics, namely, cosmetic preparations for skin care, cosmetic preparations for body care, cosmetic preparations for bath and shower, cosmetic creams, lotions, and ointments and gels for skin care; cosmetic skin fresheners and toners; cosmetic preparations for the hair and scalp, and hair lotions; Dentifrices, namely, anti-cavity dental rinses, non-medicated mouth rinses and mouth washes, cosmetic preparations for the care of mouth and teethSECTION 71 - CANCELLED—
005Pharmaceutical preparations for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders specifically excluding tissue plasminogen activators; pharmaceutical preparations for the prevention and treatment of sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; oral contraceptives; contraceptive preparations; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing preparations; pharmaceutical preparations and substances for the treatment of premenstrual syndrome, post natal depression, fluctuating hormone levels; pharmaceutical preparations and substances for infertility disorders, pharmaceutical preparations and substances for in vitro fertilization (ivf); pharmaceutical preparations in the nature of medicated dental rinses, mouth rinses, mouthwashes, dental lozenges, dental tablets and medicated chewing gum for the treatment or prevention of halitosis, cavities, gingivitis, plaque, and dry mouth; dental wax; pharmaceutical preparations in the nature of pregnancy test kits, ovulation test kits and in-vitro ovulation prediction test kits all for home use; pharmaceutical preparations in the nature of diagnostic test kits for home use for detecting urinary tract infections, for detecting menopause, for detecting vaginal pH balances and for detecting sexually-transmitted diseases, all primarily composed of test strips, collection containers, medical diagnostic reagents and assays; pharmaceutical preparations for skin care; all the foregoing specifically excluding tissue plasminogen activatorsSECTION 71 - CANCELLED—
042Scientific and technological services, namely, consulting in the field of pharmaceuticals pertaining to biotechnology, product evaluation, diagnostics, testing and inspection; pharmaceutical research and development; industrial analysis and research services in the field of pharmaceuticals and chemical analysisSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 17, 2023DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Jun 17, 2023DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 22, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 22, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 2, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 2, 2022INPCINVALIDATION PROCESSED—
May 3, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 3, 2021C71TCANCELLED SECTION 71—
Feb 17, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 17, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 1, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 1, 2015FIMPFINAL DISPOSITION PROCESSED—
May 17, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 17, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 14, 2015TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jan 14, 2015OP.TOPPOSITION TERMINATED NO. 999999—
Jan 14, 2015OP.DOPPOSITION DISMISSED NO. 999999—
Oct 3, 2014RFNPREFUSAL PROCESSED BY IB—
Sep 4, 2014OP.IOPPOSITION INSTITUTED NO. 999999—
Sep 3, 2014OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Sep 3, 2014OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Mar 24, 2014ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 11, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 11, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 7, 2014GPNXNOTIFICATION PROCESSED BY IB—
Feb 19, 2014OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 19, 2014OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 19, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 4, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 4, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Feb 4, 2014ALIEASSIGNED TO LIE—
Feb 4, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Feb 3, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 3, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 3, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 28, 2013GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 28, 2013GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 28, 2013CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 25, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 24, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 24, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 16, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 16, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 9, 2013CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Jul 6, 2013CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Jul 1, 2013RFNTREFUSAL PROCESSED BY IB—
Jun 7, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 7, 2013RFRRREFUSAL PROCESSED BY MPU—
Jun 7, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 6, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 4, 2013MAFRAPPLICATION FILING RECEIPT MAILED—
May 31, 2013DOCKASSIGNED TO EXAMINER—
May 31, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 30, 2013REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance